THE EFFECTS OF EARLY (POD 24) AND LATE PROGRESSION OVER THE DISEASE COURSE IN PATIENTS WITH FOLLICULAR LYMPHOMA.

EHA Library, Merve Yüksel, 4162252

BI-1206, AN ANTIBODY TARGETING FCγRIIB, GIVEN IN COMBINATION WITH RITUXIMAB AND ACALABRUTINIB IN SUBJECTS WITH INDOLENT B-CELL NON-HODGKIN'S LYMPHOMA

EHA Library, Laura Fogliatto, 4162253

MAINTENANCE WITH RITUXIMAB IN POST-INDUCTION MARGINAL ZONE LYMPHOMA: YES OR NO? OUR EXPERIENCE WITH LONG FOLLOW-UP.

EHA Library, MATTEO D'ADDONA, 4162254

ZANUBRUTINIB MAINTENANCE IN MCL POST-INDUCTION: A SINGLE-CENTER STUDY

EHA Library, jiaping wang, 4162255

POLATUZUMAB VEDOTIN AS AN EFFECTIVE SALVAGE THERAPY FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA RESISTANTANCE TO BTK AND BCL INHIBITORS

EHA Library, Ping Yang, 4162256

TREATMENT OUTCOME FOR GASTRIC MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA WITH HELICOBACTER PYLORI NEGATIVE

EHA Library, Sungnam Lim, 4162257

A PROSPECTIVE, TWO-ARM, PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORELABRUTINIB PLUS ZUBERITAMAB WITH OR WITHOUT LENALIDOMIDE (HILO) IN PATIENTS WITH TREATMENT-NAÏVE MARGINAL ZONE LYMPHOMA

EHA Library, He Li, 4162258

TITANIUM: AN OPEN-LABEL, MULTICENTER PHASE 1/2 STUDY OF AZD5492, A FIRST-IN-CLASS SUBCUTANEOUS CD8-GUIDED TRISPECIFIC T-CELL ENGAGER, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL MALIGNANCIES

EHA Library, Philip Thompson, 4162259

MOLECULAR GENETIC FEATURES OF MANTLE CELL LYMPHOMA

EHA Library, Nadezhda Nemscveridze, 4162260

EFFICACY OF SALVAGE THERAPY IN THE TREATMENT OF HELICOBACTER PYLORI-POSITIVE GASTRIC LOW-GRADE MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA

EHA Library, Sungnam Lim, 4162261

A CLINICAL CASE OF SUCCESSFUL USE OF IBRUTINIB IN RELAPSED MANTLE CELL LYMPHOMA (MCL) WITH CNS INVOLVEMENT AND RESULTS OF A META-ANALYSIS

EHA Library, Evgenii Kunevich, 4162262

GOLSEEK-4: A MULTICENTER PHASE 3 RANDOMIZED OPEN-LABEL STUDY COMPARING EFFICACY AND SAFETY OF GOLCADOMIDE + RITUXIMAB VS INVESTIGATOR'S CHOICE IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

EHA Library, Eliza A. Hawkes, 4162263

IBRUTINIB IN MANTLE CELL LYMHOMA: A SINGLE CENTER EXPERIENCE IN TURKEY

EHA Library, Gülcan Kökcü, 4162264

THERAPY REFRACTORY ICANS AFTER CAR T CELL THERAPY WITH BREXUCABTAGENE-AUTOLEUCEL (TECARTUS) FOR RELAPSED MANTLE CELL LYMPHOMA: SUCCESSFUL MANAGEMENT WITH INTRATHECAL TRIPLE CHEMOTHERAPY

EHA Library, Maike Meier, 4162265

ZANUBRUTINIB REAL-WORLD ANALYSIS IN MARGINAL ZONE LYMPHOMA

EHA Library, Kim Linton, 4162266

REFINING TREATMENT PARADIGMS FOR MANTLE CELL LYMPHOMA: A TAILORED APPROACH

EHA Library, Won Seog Kim, 4162267

LENALIDOMIDE-INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) COMPLICATED WITH MYOCARDITIS: A RARE BUT POTENTIALLY FATAL TOXICITY OF IMMUNOTHERAPY

EHA Library, Xiyang Liu, 4162268

CHOLLESTEROLL METABOLLIIC REPROGRAMMIING DRIIVES THE ONSET OF DLBCL AND REPRESENTS A PROMIISIING THERAPEUTIIC TARGET

EHA Library, Lili Zhou, 4162269

EFFICACY OF ZANUBRUTINIB PLUS R-CHOP VERSUS R-CHOP ALONE IN NEWLY DIAGNOSED INTRAVASCULAR LARGE B-CELL LYMPHOMA: A RETROSPECTIVE STUDY

EHA Library, Chao Chen, 4162270

REAL-WORLD STUDY OF GOLIDOCITINIB FOR THE TREATMENT OF RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA: RETROSPECTIVE DATA FROM MEDICAL CENTERS IN CHINA

EHA Library, Yan Gao, 4162271

A PROPOSED PROGNOSTIC SCORE INCLUDING CIRCULATING FREE DNA (CFDNA) CONCENTRATION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL); SINGLE CENTRE STUDY

EHA Library, Esraa Jamal, 4162272

POLATUZUMAB VEDOTIN AND GLOFITAMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: DATA FROM THE ITALIAN COMPASSIONATE USE PROGRAM

EHA Library, Giuseppe Gritti, 4162273

OUTCOME OF BURKITT LYMPHOMA IN REAL-WORLD SETTING: A MULTICENTER RETROSPECTIVE STUDY ON 104 CONSECUTIVE CASES DIAGNOSED AND TREATED IN KAZAKHSTAN OVER THE LAST DECADE

EHA Library, Saule Gabbassova, 4162274

AZACYTIDINE PLUS RITUXIMAB-GEMCITABINE-OXALIPLATIN AS SALVAGE TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Dongfeng Zeng, 4162275

PROGNOSTIC IMPACT OF NOTCH1/FBXW7/PHF6 MUTATIONS IN PEDIATRIC T-LYMPHOBLASTIC LYMPHOMA: A RUSSIAN MULTICENTER ANALYSIS

EHA Library, Volchkov Egor, 4162276

CAR-T TREATMENT STRATEGY FOR B-CELL LYMPHOMA: HIGH COMPLETE RESPONSE RATE IN M2 MACROPHAGES AND GRANULOCYTES DEFICIENCY IMMUE MICROENVIRONMENT

EHA Library, Danyang Li, 4162277

THE PROGNOSTIC ROLE OF EBV IN POST-TRANSPLANT- LYMPHOPROLIFERATIVE DISORDERS: A RETROSPECTIVE SINGLE CENTER STUDY

EHA Library, Periana Minga, 4162278

DURVALUMAB AND ACALABRUTINIB FOR RELAPSED/REFRACTORY (R/R) HIGH-GRADE B-CELL LYMPHOMA: MOST15, OPEN LABEL PHASE II SUB-STUDY OF THE MOLECULAR SCREENING AND THERAPEUTICS IN LEUKAEMIA AND LYMPHOMA FRAMEWORK

EHA Library, Steven Lane, 4162279

COMBINATION OF MITOXANTRONE HYDROCHLORIDE LIPOSOME WITH CHIDAMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T CELL LYMPHOMA: UPDATED RESULTS OF THE PHASE II STUDY

EHA Library, Zhi-Ming Li, 4162280

PITUITARY INVOLVEMENT IN DLBCL AND IVLBCL: A COMBINED FUNCTIONAL AND RADIOLOGICAL ANALYSIS

EHA Library, Hajime Sakuma, 4162281

ADJUSTING SERUM ß2-MICROGLOBULIN LEVELS (Sß2M) ACCORDING TO RENAL FUNCTION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): IMPACT ON PROGNOSTIC SIGNIFICANCE

EHA Library, Theodoros Vassilakopoulos, 4162282

IMMUNE DYSREGULATION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AND HIGH-GRADE B-CELL LYMPHOMA (HGBL) WITH MYC, BCL2, AND/OR BCL6 REARRANGEMENTS: A COMPARATIVE ANALYSIS OF R-CHOP VERSUS R-DA-EPOCH REGIMENS.

EHA Library, Macarena Castillo Godoy, 4162283

COMBINATION OF BASELINE CA125 AND EOT FDG-PET DYNAMICALLY STRATIFIES FAILURE RISK IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA TREATED WITH DA-EPOCH-R: A REAL-LIFE RETROSPECTIVE ANALYSIS.

EHA Library, Alberto Fresa, 4162284

TREATING PRIMARY LARGE B-CELL LYMPHOMA OF IMMUNE-PRIVILEGED SITES, ARISING IN CENTRAL NERVOUS SYSTEM (PCNS-LBCL) AND VITREORETINAL (PVR-LBCL) BEYOND INDUCTION THERAPY: THE ROLE OF CONSOLIDATION AND MAINTENANCE THERAPY.

EHA Library, Maria BOUZANI, 4162285

REAL WORLD OUTCOMES OF HISTONE DEACETYLASE INHIBITORS IN RELAPSED/ REFRACTORY PERIPHERAL T CELL LYMPHOMA: A MULTICENTRIC RETROSPECTIVE STUDY IN ARGENTINA

EHA Library, Laura Korin, 4162286

ROLE OF PET CT IN DETECTION OF BONE MARROW INFILTRATION IN PEDIATRIC MATURE B-CELL LYMPHOMA

EHA Library, Hani Abdel Rahman Sayed, 4162287

SOMETIMES OLD IS GOLD - DOES MINE RETAIN ITS GLEAM IN R/R DLBCL PATIENTS INELIGIBLE FOR ASCT?

EHA Library, Leonardo Maia Moço, 4162288

REAL-WORLD OUTCOMES OF PEDIATRIC T-CELL LYMPHOBLASTIC LYMPHOMA: EXTERNAL CONTROL COMPARISON OF CONVENTIONAL CHEMOTHERAPY VS. BORTEZOMIB-CONTAINING REGIMENS

EHA Library, Bo Kyung Kim, 4162289

BRENTUXIMAB VEDOTIN PLUS CHP-LIKE REGIMEN FOR THE FIRST-LINE TREATMENT OF PTCL PATIENTS: A REAL-WORLD SINGLE CENTER STUDY

EHA Library, Fang shu Guan, 4162291

THE EFFICACY AND SAFETY OF ORELABRUTINIB COMBINED WITH RITUXIMAB AND HIGH-DOSE METHOTREXATE IN NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE STUDY

EHA Library, Shujuan Wen, 4162292

TESTICULAR LYMPHOMA OF 63 PATIENTS: A CHINESE RETROSPECTIVE, REAL-WORLD STUDY

EHA Library, Xudong Zhang, 4162293

CLINICAL OUTCOMES COMPARISON BETWEEN TISAGENLECLEUCEL AND ALLOGENEIC HSCT FOR RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA: A DUAL-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Youngwoo Jeon, 4162294

LONG-TERM FOLLOW-UP OF RESPONSE-DRIVEN DOSE-INTENSIFIED IMMUNOCHEMOTHERAPY ± AUTOLOGOUS STEM CELL TRANSPLANTATION IN PREVIOUSLY UNTREATED PATIENTS WITH HIGH-RISK AGGRESSIVE B-CELL LYMPHOMA: UPDATE FROM A SINGLE-CENTER EXPERIENCE

EHA Library, Ting Xie, 4162295

GEMCITABINE AND OXALIPLATIN +/- RITUXIMAB AS A SALVAGE REGIMEN IN RELAPSED OR REFRACTORY POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER: GUY'S HOSPITAL SINGLE-CENTRE EXPERIENCE

EHA Library, Craig Lennie, 4162296

A MULTICENTER, OPEN-LABEL, PHASE 3, RANDOMIZED TRIAL OF DUVELISIB VS INVESTIGATOR'S CHOICE (GEMCITABINE OR BENDAMUSTINE) IN RELAPSED/REFRACTORY NODAL T-CELL LYMPHOMA WITH T-FOLLICULAR HELPER PHENOTYPE

EHA Library, Kate Cwynarski, 4162297

EFFICACY AND SAFETY OF GLOFITAMAB COMBINED WITH TISLELIZUMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A PILOT STUDY IN CHINA

EHA Library, De Zhou, 4162298

MULTIPLE INFUSIONS OF CART CELLS TREATMENT FOR HEMATOLOGIC MALIGNANT TUMOR(PH-B-ALL, DLBCL, MM)

EHA Library, Yihao Wang, 4162299

SELINEXOR IN COMBINATION WITH R-EPOCH FOR PATIENTS WITH PREVIOUSLY UNTREATED HIV-ASSOCIATED DLBCL: A SINGLE-CENTER, PROSPECTIVE, SINGLE-ARM TRIAL

EHA Library, Chaoyu Wang, 4162300

GOLIDOCITINIB COMBINED WITH CHOP IN NEWLY-DIAGNOSED PERIPHERAL T-CELL LYMPHOMA: PRELIMINARY RESULTS FROM A PHASE 1/2 CLINICAL TRIAL

EHA Library, Wei Zhang, 4162301

ORELABRUTINIB PLUS LENALIDOMIDE AND RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE-B CELL LYMPHOMA

EHA Library, Jie-Fei Bai, 4162302

CHECKPOINT INHIBITORS SHOW HIGH RESPONSE RATE IN RELAPSED OR REFRACTORY GRAY ZONE LYMPHOMAS

EHA Library, Ivan Dlouhy, 4162303

FIRST-LINE SELINEXOR IN COMBINATION WITH R-CHOP FOR EBV-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA (XPLORE): A SINGLE-ARM, PHASE IB/II TRIAL

EHA Library, Qingqing Cai, 4162304

EDUCATIONAL IMPACT OF LIVE AND ONLINE ENDURING CME/CE ON HEMATOLOGY/ONCOLOGY CARE TEAM SKILLS MANAGING LYMPHOMAS WITH BISPECIFIC ANTIBODIES: PRE-/POST- EDUCATION ASSESSMENT

EHA Library, Sarah Elizabeth Bomba, 4162305

HIGH-DOSE THIOTEPA COMBINED WITH RITUXIMAB AND POMALIDOMIDE IS A PERFECT ALTERNATIVE CHEMOTHERAPY REGIMEN FOR RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Xia Zhao, 4162306

THE IMPACT OF VOLUMETRIC MEASUREMENTS ASSESSED BY FDG-PET/CT ON SURVIVAL AND PROGNOSIS IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Esra Durmazer, 4162307

VALIDATION OF ESTABLISHED PROGNOSTIC SCORES AND INTEGRATION OF EASILY AVAILABLE BIOMARKERS IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA - A SINGLE-CENTER EXPERIENCE.

EHA Library, Greta Scapinello, 4162308

STUDY OF AUTOLOGOUS VS. ALLOGENEIC STEM CELL TRANSPLANTATION IN 56 PATIENTS WITH HIGH RISK EXTRANODAL NK/T -CELL LYMPHOMA

EHA Library, Haiwen Huang, 4162309

REAL-LIFE EXPERIENCE WITH MOGAMULIZUMAB IN PRIMARY CUTANEOUS T-CELL LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Antonio Giordano, 4162310

CLINICAL, ECONOMIC, AND HUMANISTIC OUTCOMES OF FIRST-LINE HIGH-RISK LARGE B-CELL LYMPHOMA: A SERIES OF SYSTEMATIC LITERATURE REVIEWS

EHA Library, Yi Lin, 4162311

TREATMENT OF PATIENTS WITH HISTIOCYTOSIS: RETROSPECTIVE MONOCENTRIC EXPERIENCE

EHA Library, Marianna Criscuolo, 4162312

ORAL LENALIDOMIDE OR BTK INHIBITORS AS MAINTENANCE THERAPY DEMONSTRATED DURABLE EFFICACY AFTER FIRST REMISSION IN PCNSL PATIENTS

EHA Library, Huiying Zhu, 4162313

CLINICAL AND RADIOLOGICAL PREDICTION MODELS FOR RANDOM SKIN BIOPSY POSITIVITY IN SUSPECTED INTRAVASCULAR LARGE B-CELL LYMPHOMA: DEVELOPMENT AND INTERNAL VALIDATION

EHA Library, Hajime Sakuma, 4162314

INFECTIOUS RISK OF RELAPSED/ REFRACTORY LYMPHOMA PATIENTS TREATED WITH CD3/CD20 BISPECIFIC ANTIBODIES - REAL WORLD DATA

EHA Library, Fernanda Seganfredo, 4162315

PROGNOSTIC ANALYSIS AND NOMOGRAM MODEL CONSTRUCTION FOR DIFFUSE LARGE B-CELL LYMPHOMA IN CHINESE ADOLESCENT AND YOUNG ADULT (AYA) POPULATION

EHA Library, Donghua He, 4162316

PET-CT-ADAPTED TREATMENT FOR EARLY-STAGE DIFFUSE LARGE B-CELL LYMPHOMA WITHOUT RISK FACTORS: PRELIMINARY ANALYSIS FROM THE GATLA GROUP

EHA Library, Fernando Warley, 4162317

IMPACT OF RELATIVE DOSE INTENSITY OF CHEMOTHERAPY IN ELDERLY PATIENTS WITH EXTRANODAL NK/T-CELL LYMPHOMA

EHA Library, Wanyue Zhao, 4162318

CLINICAL FEATURES AND PROGNOSTIC FACTORS OF INTRAVASCULAR LARGE B-CELL LYMPHOMA: A COHORT STUDY OF 20 PATIENTS FROM 2018 TO 2024

EHA Library, Mingzhi Zhang, 4162319

MYC STATUS IN DIFFUSE LARGE B-CELL AND AGGRESSIVE LYMPHOMA: TAKE INTO ACCOUNT REARRANGEMENTS BUT DON'T FORGET GAINS AND AMPLIFICATIONS

EHA Library, Sofia Garcia-Ferreiro, 4162320

CLINICAL FEATURES AND TREATMENT OUTCOMES OF HIV ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA: ANALYSIS OF THE THAI LYMPHOMA STUDY GROUP REGISTRY.

EHA Library, KANNADIT PRAYONGRATANA, 4162321

DOSE-REDUCED POLA-R-CHP FOR FRONTLINE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA IN ELDERLY AND COMORBID PATIENTS

EHA Library, Kunal Shah, 4162323

FIRST-LINE THERAPY OUTCOMES IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: ? LARGE COHORT MULTICENTER STUDY

EHA Library, Vladislav Markelov, 4162324

POLATUZUMAB-R-CHP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA. A RETROSPECTIVE STUDY.

EHA Library, Alejandro Bobes, 4162325

AN ANALYSIS OF THE RELATIONSHIP OF TRIGLYCERIDE GLUCOSE INDEX WITH DIFFUSE LARGE B-CELL LYMPHOMA PROGNOSIS: A RETROSPECTIVE STUDY

EHA Library, QingQing Luo, 4162326

ZANUBRUTINIB MAINTENANCE AFTER AUTOLOGOUS STEM CELL TRANSPLANT IN HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-ARM PROSPECTIVE STUDY

EHA Library, yanli lai, 4162327

BGB-11417-302, A PHASE?3, RANDOMIZED, DOUBLE-BLIND STUDY OF SONROTOCLAX (BGB-11417) + ZANUBRUTINIB VS PLACEBO + ZANUBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA

EHA Library, Marie Hughes, 4162328

GOLIDOCITINIB COMBINED WITH CHOP IN TREATMENT-NAÏVE MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA: PRELIMINARY RESULTS FROM A PHASE 2 MULTICENTER, SINGLE-ARM GOAL STUDY

EHA Library, Li Wang, 4162329

CLINICAL IMPLICATIONS OF CEREBROSPINAL FLUID CTDNA AND INTERLEUKIN-10 IN PROGNOSIS PREDICTION AND DISEASE MONITORING FOR PRIMARY CENTRAL NERVOUS LYMPHOMA

EHA Library, Zhe Zhuang, 4162330

A NOVEL TREATMENT REGIMEN FOR NEWLY DIAGNOSED CAEBV INDUCING A HIGH RESPONSE RATE: PD-1 INHIBITOR, L-ASPARGASE AND CHIDAMIDE

EHA Library, Yi-ao Di, 4162331

STAGING BONE MARROW BIOPSIES AND INTERIM PET SCANS IN DLBCL: ESSENTIAL OR DISPENSABLE

EHA Library, Michael Caruana Dingli, 4162332

INCREASED TIGIT EXPRESSION CORRELATES WITH IMPAIRED NK CELL FUNCTION IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, hui lu, 4162333

EFFICACY AND SAFETY ANALYSIS OF ZANUBRUTINIB COMBINED WITH CHEMOTHERAPY FOR RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, hongyun xing, 4162334

REAL-WORLD DATA OF AZACITIDINE FOR RELAPSED/REFRACTORY NODAL T-FOLLICULAR HELPER CELL LYMPHOMA IN 10 PATIENTS

EHA Library, Philipp Faustmann, 4162335

POLATUZUMAB VEDOTIN COMBINED WITH ORELABRUTINIB AND RITUXIMAB (PRO) DEMONSTRATES RAPID AND PROFOUND THERAPEUTIC EFFICACY IN TREATMENT-NAÏVE ELDERLY PATIENTS WITH NON-GERMINAL CENTER B-CELL (NON-GCB) OR GCB WITH MUM1+ DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, wenyu shi, 4162336

THE CMOP±R REGIMEN SHOWS HIGH EFFICACY AS A FIRST-LINE TREATMENT FOR NON-HODGKIN'S LYMPHOMA: A PHASE II CLINICAL TRIAL WITH MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON (MAIC) ANALYSIS

EHA Library, Tao You, 4162337

CHARACTERISTICS OF DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WITH RITUXIMAB INDUCED ACUTE THROMBOCYTOPENIA

EHA Library, Jianai Sun, 4162338

EFFICACY OF PEMETREXED-BASED REGIMENS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE-CENTER EXPERIENCE

EHA Library, Tarlan Kehtari, 4162339

OUTCOMES OF ZANUBRUTINIB COMBINED WITH POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA-ZR-CHP) IN THE TREATMENT OF PATIENTS WITH EXTRANODAL (EN) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN A REAL-WORLD SETTING

EHA Library, Caixia Li, 4162340

PRIMARY BRAINSTEM LYMPHOMA: CLINICAL CHARACTERISTICS, TREATMENT METHODS, AND PROGNOSTIC FACTORS OF 56 PATIENTS

EHA Library, Wenhui Guo, 4162341

OUTCOMES AND SURVIVAL IN ELDERLY (≥60 YEARS) PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: A SINGLE-CENTER EXPERIENCE OF 186 PATIENTS

EHA Library, Kubilay Tay, 4162342

CHEMO-FREE REGIMENS CONTAINING GLOFITAMAB ARE SIGNIFICANTLY BENEFICIAL FOR RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS WITH TP53 GENE MUTATIONS: REAL-WORLD DATA FROM MULTI-CENTERS IN CHINA

EHA Library, Xia Zhao, 4162344

THE ROLE OF INDUCTION RADIOTHERAPY AT A REDUCED DOSE FOLLOWED BY HIGH DOSE CHEMOTHERAPY IN CENTRAL NERVOUS SYSTEM LYMPHOMA: NEUROLOGIC SYMPTOMS CONTROL AND SURVIVAL BENEFIT

EHA Library, Maher Salamoon, 4162345

EFFICACY AND SAFETY OF BRENTUXIMAB VEDOTIN COMBINED WITH MITOXANTRONE HYDROCHLORIDE LIPOSOME IN REFRACTORY/RELAPSED CD30+ PRIMARY CUTANEOUS OR CUTANEOUS-INFILTRATED T-CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS

EHA Library, Liufang Gu, 4162346

EFFICACY AND SAFETY OF ANTI-PD-1/PD-L1 ANTIBODIES IN PATIENTS WITH RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A META-ANALYSIS

EHA Library, Liang Wang, 4162347

EFFICACY AND SAFETY OF ZANUBRUTINIB IN COMBINATION WITH RITUXIMAB AND HIGH-DOSE METHOTREXATE FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DIFFUSE LARGE B-CELL LYMPHOMA .

EHA Library, hongyun xing, 4162348

IMMUNE CHECKPOINT INHIBITORS IN AGGRESSIVE B-CELL LYMPHOMAS: A RETROSPECTIVE STUDY ON PATHOLOGICAL FEATURES, RESPONSE AND SURVIVAL

EHA Library, Rita Nader, 4162349

LATE RECURRENCE IN PEDIATRIC MATURE B CELL LYMPHOMA; CAUSES, PROGNOSIS AND TREATMENT OUTCOME

EHA Library, Hani Abdel Rahman Sayed, 4162350

EFFICACY AND SAFETY STUDY OF LINPERLISIB COMBINED WITH AZACITIDINE IN THE TREATMENT OF PERIPHERAL T-CELL LYMPHOMA

EHA Library, hongyun xing, 4162351

ORELABRUTINIB PLUS R-CHOP-LIKE REGIMEN IN DOUBLE-EXPRESSOR DIFFUSE LARGE B-CELL LYMPHOMA: REAL-WORLD RETROSPECTIVE DATA

EHA Library, Lingke Zhang, 4162352

FIRST-LINE TREATMENT WITH POLATUZUMAB VEDOTIN IMPROVES EFFICACY AND SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTER RETROSPECTIVE ANALYSIS

EHA Library, Jianxia He, 4162353

ANALYSIS OF GENETIC MUTATION PROFILE AND CNS PHARMACOKINETICS IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA PATIENTS RESPONDING TO NOVEL EMAVUSERTIB (IRAK4I) AND BTKI COMBINATION

EHA Library, Christian Grommes, 4162354